TABLE 3.
Management Decisions in 509 Adults and Children with Aseptic Meningitis.
| Adults (n=404) |
Children (n=105) |
Total (n=509) |
P valuea | |
|---|---|---|---|---|
| Management Decisions, n (%) | ||||
| Admission to the Hospital | 386 (95.6) | 105 (100) | 491 (96.5) | 0.769 |
| Median duration of hospitalization, days (range) | 4 (1–34) | 3 (1–33) | 4 (1–34) | 0.210 |
| Empiric Antibiotic therapy | 297 (73.5) | 97 (92.3) | 394 (77.4) | <0.001 |
| Empiric Acyclovir therapy | 80 (19.8) | 7 (6.6) | 87 (17.1) | 0.001 |
| Head CTb scan done | 349 (86.3) | 35 (33.3) | 384 (75.4) | <0.001 |
| Normal | 100 (0) | 100 (0) | 100 (0) | N/A |
| MRIb of Brain done | 115 (28.5) | 10 (9.5) | 125 (24.5) | <0.001 |
| Meningeal enhancement | 9 (7.8) | 2 (20) | 11(8.8) | N/A |
| Adverse clinical outcomec | 0 (0) | 0 (0) | 0 (0) | N/A |
a
P value comparing adult and pediatric cohorts
b
CT: Computerized Tomography; MRI: Magnetic Resonance Imaging
c
Glasgow outcome scale from 1–4.